• New Drugs Approved
    • 2024 Approvals
    • 2023 Approvals
  • Health and Medical Research News
    • Arthritis
    • Bronchitis
    • Cancer
    • Diabetes
    • Eye
    • Heart Conditions
    • Vaccines and Infections
    • Mental Health
    • Neurology
    • Pain Conditions
    • Skin Conditions
    • Stomach & Intestine
FDA Approves Sohonos for Fibrodysplasia Ossificans Progressiva on August 16, 2023

FDA Approves Sohonos for Fibrodysplasia Ossificans Progressiva on August 16, 2023

by B Jamerson | Jul 22, 2024 | 2023 Approvals, Drug approvals, New Drugs Approved

What is Sohonos prescribed for?   Sohonos is prescribed to reduce the volume of new heterotopic ossification in adults and pediatric patients (aged 8 years and older for females and 10 years and older for males) with fibrodysplasia ossificans progressiva....
FDA Approves Elrexfio for Multiple Myeloma on August 14, 2023

FDA Approves Elrexfio for Multiple Myeloma on August 14, 2023

by B Jamerson | Jul 22, 2024 | 2023 Approvals, Drug approvals

What is Elrexfio prescribed for?   Elrexfio is prescribed to treat adults with relapsed or refractory multiple myeloma who have received at least four prior therapies. What is the name of the drug and what does it do? The name of the drug is Elrexfio,...
FDA Approves Talvey for Multiple Myeloma on August 9, 2023

FDA Approves Talvey for Multiple Myeloma on August 9, 2023

by B Jamerson | Jul 22, 2024 | 2023 Approvals, Drug approvals

What is Talvey prescribed for?   Talvey is prescribed to treat adults with relapsed or refractory multiple myeloma who have received at least four prior therapies. What is the name of the drug and what does it do? The name of the drug is Talvey, pronounced...
FDA Approves XDEMVY for Treating Demodex Blepharitis on July 25, 2023

FDA Approves XDEMVY for Treating Demodex Blepharitis on July 25, 2023

by B Jamerson | Jul 22, 2024 | 2023 Approvals, Drug approvals, New Drugs Approved

What is XDEMVY prescribed for?   XDEMVY is prescribed to treat a parasitic infection of the eye (Demodex blepharitis) that can  especially affect the eyelids. What is the name of the drug and what does it do? XDEMVY, pronounced X-DEM-VEE, (generic name:...
FDA Approves Leqembi for Alzheimer’s Disease on on July 6, 2023

FDA Approves Leqembi for Alzheimer’s Disease on on July 6, 2023

by B Jamerson | Jul 22, 2024 | 2023 Approvals, Drug approvals, New Drugs Approved

What is Leqembi prescribed for?   Leqembi is prescribed to treat Alzheimer’s disease for people in the early stages of the disease. What is the name of the drug and what does it do?  The U.S. Food and Drug Administration has approved Leqembi (generic...
Page 19 of 22« First«...10...1718192021...»Last »

Latest Posts

  • Research Progress for Chronic Bronchitis: Sulforaphane Strengthens Lung Defenses
  • Do All Men with Prostate Cancer Get the Same Treatment? A Look at Racial and Ethnic Gaps
  • New Light on Osteoarthritis: Innovative Imaging Techniques Unveil Early Joint Damage
  • New Combination Therapy Shows Promise for Advanced Urinary Tract Cancer
  • New Discovery Could Lead to Better Treatments for Rheumatoid Arthritis

ScienceMyHealth is a product of iSimcha.

Navigate

HomePage

Blog

 

Company

About Us

Contact Us

© 2025 iSimcha

Privacy Policy

Terms of Service